Gut Microbiota in Health and Disease, Physiol. Rev, vol.90, pp.859-904, 2010. ,
The immune system and the gut microbiota: friends or foes?, Nat. Rev. Immunol, vol.10, pp.735-779, 2010. ,
URL : https://hal.archives-ouvertes.fr/hal-01204303
Microbial Digestion of Complex Carbohydrates in Man, Proc. Nutr. Soc, vol.43, pp.35-44, 1984. ,
Vitamin B12 synthesis by human small intestinal bacteria, Nature, vol.283, pp.781-782, 1980. ,
The gut microbiota as an environmental factor that regulates fat storage, Proc. Natl. Acad. Sci. USA, vol.101, pp.15718-15741, 2004. ,
How host-microbial interactions shape the nutrient environment of the mammalian intestine, Annu. Rev. Nutr, vol.22, pp.283-307, 2002. ,
Microbes and microbial effector molecules in treatment of inflammatory disorders, Immunol. Rev, vol.245, pp.27-44, 2012. ,
Richness of human gut microbiome correlates with metabolic markers, Nature, vol.500, pp.541-547, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-01190602
Role of gut microflora in the development of obesity and insulin resistance following high-fat diet feeding, Pathol. Biol, vol.56, pp.305-314, 2008. ,
URL : https://hal.archives-ouvertes.fr/inserm-00408892
Commensal bacteria at the interface of host metabolism and the immune system, Nat. Immunol, vol.14, pp.676-84, 2013. ,
MR1 presents microbial vitamin B metabolites to MAIT cells, Nature, vol.491, pp.717-740, 2012. ,
Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist, Cell Metab, vol.17, pp.225-260, 2013. ,
Control of the peroxisomal ? -oxidation pathway by a novel family of nuclear hormone receptors, Cell, vol.68, pp.879-87, 1992. ,
The organization, promoter analysis, and expression of the human PPARgamma gene, J Biol Chem, vol.272, pp.18779-89, 1997. ,
PPARgamma as a new therapeutic target in inflammatory bowel diseases, Gut, vol.55, pp.1341-1350, 2006. ,
Loss-of-function mutations in PPAR gamma associated with human colon cancer, Mol. Cell, vol.3, pp.799-804, 1999. ,
Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPARgamma and RelA, Nat. Immunol, vol.5, pp.104-116, 2004. ,
Mechanisms underlying the resistance to diet-induced obesity in germ-free mice, Proc Natl Acad Sci, vol.104, pp.979-84, 2007. ,
, ? and inflammatory bowel disease: a new therapeutic PPAR? target for ulcerative colitis and Crohn's disease, vol.7, pp.329-360, 2001.
Differentiation and reversal of malignant changes in colon cancer through PPAR?, Nat. Med, vol.4, pp.1046-52, 1998. ,
PPARgamma and colon and rectal cancer: associations with specific tumor mutations, aspirin, ibuprofen and insulin-related genes (United States), Cancer Causes Control, vol.17, pp.239-288, 2006. ,
Fat poetry: a kingdom for PPAR gamma, Cell Res, vol.17, pp.486-511, 2007. ,
Identification of NF-? B Modulation Capabilities within Human Intestinal Commensal Bacteria, J. Biomed. Biotechnol, p.282356, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-01000996
Butyrate Produced by Commensal Bacteria Potentiates Phorbol Esters Induced AP-1 Response in Human Intestinal Epithelial Cells, PLoS One, vol.7, p.52869, 2012. ,
URL : https://hal.archives-ouvertes.fr/hal-01190699
ANGPTL4 expression induced by butyrate and rosiglitazone in human intestinal epithelial cells utilizes independent pathways, Am. J. Physiol. Gastrointest. Liver Physiol, vol.304, pp.1025-1062, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-01001518
The microbiome and butyrate regulate energy metabolism and autophagy in the mammalian colon, Cell Metab, vol.13, pp.517-543, 2011. ,
Short chain fatty acids stimulate Angiopoietin-like 4 synthesis in human colon adenocarcinoma cells by activating PPAR?, Mol. Cell. Biol, vol.33, pp.1303-1319, 2013. ,
Fecal water as a non-invasive biomarker in nutritional intervention: comparison of preparation methods and refinement of different endpoints, Nutr. Cancer, vol.57, pp.158-67, 2007. ,
Short chain fatty acids in human large intestine, portal, hepatic and venous blood, Gut, vol.28, pp.1221-1228, 1987. ,
The gut microbiota as an environmental factor that regulates fat storage, Proc Natl Acad Sci, vol.101, pp.15718-15741, 2004. ,
Enterococcus faecalis from newborn babies regulate endogenous PPARgamma activity and IL-10 levels in colonic epithelial cells, Proc. Natl. Acad. Sci. USA 105, pp.1943-1951, 2008. ,
Modulation of PPAR activity via phosphorylation, Biochim. Biophys. Acta, vol.1771, pp.952-60, 2007. ,
Gut microbiota: a potential new territory for drug targeting, Nat Rev Drug Discov, vol.7, pp.123-132, 2008. ,
Human intestinal metagenomics: state of the art and future, Curr. Opin. Microbiol, vol.16, pp.232-241, 2013. ,
Modulating nuclear receptor function: may the phos be with you, J. Clin. Invest, vol.103, pp.1617-1625, 1999. ,
Phosphorylation control of nuclear receptors, Methods Mol. Biol, vol.647, pp.251-66, 2010. ,
Transcriptional activation by peroxisome proliferator-activated receptor gamma is inhibited by phosphorylation at a consensus mitogen-activated protein kinase site, J. Biol. Chem, vol.272, pp.5128-5160, 1997. ,
Insulin-and mitogen-activated protein kinase-mediated phosphorylation and activation of peroxisome proliferatoractivated receptor gamma, J. Biol. Chem, vol.271, pp.31771-31775, 1996. ,
, Scientific RepoRts |, vol.7, p.43199
Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation, Cell, vol.80, pp.179-85, 1995. ,
Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine, J. Biol. Chem, vol.270, pp.7420-7426, 1995. ,
Decreased fat storage by Lactobacillus paracasei is associated with increased levels of angiopoietin-like 4 protein (ANGPTL4), PLoS One, vol.5, 2010. ,
Attenuation of colon inflammation through activators of the retinoid X receptor (RXR)/peroxisome proliferator-activated receptor gamma (PPARgamma) heterodimer. A basis for new therapeutic strategies, J. Exp. Med, vol.193, pp.827-865, 2001. ,
A novel therapy for colitis utilizing PPAR-gamma ligands to inhibit the epithelial inflammatory response, J. Clin. Invest, vol.104, pp.383-392, 1999. ,
Peroxisome proliferator activated receptor gamma in colonic epithelial cells protects against experimental inflammatory bowel disease, Gut, vol.55, pp.1104-1117, 2006. ,
PPAR? in Inflammatory Bowel Disease, PPAR Res, p.620839, 2012. ,
Polymorphisms in NF-? B, PXR, LXR, PPAR? and risk of inflammatory bowel disease, World J. Gastroenterol, vol.17, pp.197-206, 2011. ,
Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis, vol.2, p.1202, 2013. ,
New bacterial species associated with chronic periodontitis, J. Dent. Res, vol.82, pp.338-382, 2003. ,
A Crypt-Specific Core Microbiota Resides in the Mouse Colon, vol.3, pp.116-128, 2012. ,
, Growth (Lakeland), 1950.
Commensal Streptococcus salivarius Modulates PPAR? Transcriptional Activity in Human Intestinal Epithelial Cells, PLoS One, vol.10, p.125371, 2015. ,